Medicine and Dentistry
Transplantation
90%
Mesenchymal Stem Cell
81%
Patient
73%
Therapeutic Procedure
47%
Analysis
37%
Secondary Acute Myeloid Leukemia
36%
Acute Leukemia
36%
Biological Marker
36%
Myelodysplastic Syndrome
27%
Cell Transplantation
27%
Hazard Ratio
25%
Spontaneous Remission
23%
Follow up
23%
Programmed Cell Death
19%
Allogeneic Stem Cell Transplantation
18%
Acute Myeloid Leukemia
18%
Disease
18%
Regulatory T Cell
18%
Myeloablative Conditioning
18%
Cancer Cell
18%
Breast Cancer
18%
Long Term Survival
18%
Chronic Lymphocytic Leukemia
18%
Reduced Intensity Conditioning
18%
Elderly Patient
18%
Interference
18%
Graft Versus Leukemia Effect
18%
Reproducibility
18%
Spirometry
18%
Hospital
18%
Allograft
18%
Hematopoietic Cell
18%
Bone Marrow Microenvironment
18%
Donor
17%
Marker
14%
Non-Relapse Mortality
14%
Dimer
12%
Overall Survival
9%
Chronic Myelomonocytic Leukemia
9%
Culture
9%
Myeloproliferative Neoplasm
9%
Laboratory
8%
Assay
8%
Sibling
8%
Therapeutics
7%
Stroma
6%
Event Free Survival
6%
Bone Marrow
6%
Intensive Care Unit
6%
Regression Analysis
6%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Transplant Procedure
84%
Graft-Versus-Host Disease
75%
Regulatory T Cell
20%
Immunosuppressive Drug
10%
Stroma
6%
Cytotoxic T-Cell
6%
Immunosuppression
5%
Engraftment
5%